Important: Antigen retrieval conditions, antibody concentration, and incubation conditions are antibody-dependent. When product-specific IHC conditions are provided on a NeoBiotechnologies product page or datasheet, those conditions should be used in place of the general conditions below.
NeoBiotechnologies antibodies are intended for Research Use Only (RUO) and are not approved for diagnostic use.
Use appropriate laboratory PPE and handle solvents, DAB, and other reagents according to their current Safety Data Sheets.
Do not allow tissue sections to dry at any point after rehydration.
Antigen retrieval is antibody-dependent. Refer to the product-specific IHC conditions whenever available.
For antibodies validated using high-pH heat-induced epitope retrieval (HIER), a commonly used NeoBiotechnologies manual condition is:
For antibodies requiring low-pH retrieval, use an appropriate citrate-based retrieval buffer, typically 10 mM citrate, pH 6.0.
Some antibodies perform optimally with no antigen retrieval or require alternative retrieval conditions. The antibody-specific product page or datasheet should take precedence over this general protocol.
Following retrieval, wash slides 3 × 3–5 minutes in PBS or TBS.
Follow the blocking reagent manufacturer’s instructions when they differ from the general conditions above.
A commonly used NeoBiotechnologies manual IHC condition for many antibodies is 1–2 µg/mL for 30 minutes at room temperature. This should be treated as a starting condition only when antibody-specific conditions are unavailable.
Prepare DAB immediately before use according to the manufacturer’s current instructions.
DAB development time may require optimization depending on antigen abundance, primary antibody concentration, and detection system.
The counterstain should provide clear nuclear definition without obscuring the DAB signal.
Dehydrate the slides through graded ethanol:
Clear in 2–3 changes of xylene or equivalent clearing reagent.
Apply a compatible permanent mounting medium and coverslip.
Allow the mounting medium to cure before imaging or long-term storage.
Appropriate controls should be included with each IHC experiment.
Positive control: Use tissue known to express the target antigen to confirm that the staining system and antibody are functioning as expected.
Negative reagent control: Process a comparable tissue section under identical conditions while omitting the primary antibody. This control helps identify staining produced by the detection system or other reagents.
Known negative tissue: When available, tissue known not to express the target can provide additional evidence of staining specificity.
Controls should undergo the same fixation, processing, retrieval, detection, and staining conditions as the experimental samples whenever possible.
Evaluate staining according to:
Interpretation should consider both staining intensity and localization. Staining intensity alone should not be interpreted as quantitative protein expression unless the assay has been specifically validated for quantitative or semi-quantitative analysis.
Antigen retrieval and primary antibody concentration are among the most important variables in IHC optimization. Excessive retrieval may damage tissue morphology or reduce staining for retrieval-sensitive epitopes, while insufficient retrieval may result in weak staining.
When optimizing an antibody for a new tissue type or staining platform, evaluate antibody concentration and retrieval conditions systematically rather than altering multiple variables simultaneously.
Automated IHC instruments may use different reagent concentrations, temperatures, retrieval conditions, and incubation times. For automated staining, follow the validated protocol for the specific instrument and detection chemistry.
For Research Use Only. Not for use in diagnostic procedures.
Formalin-fixed, paraffin-embedded human Skin stained with Stratifin Mouse Monoclonal Antibody (CPTC-SFN-2).
Formalin-fixed, paraffin-embedded human Testis stained with 14-3-3E Mouse Monoclonal Antibody (CPTC-YWHAE-1).
Formalin-fixed, paraffin-embedded human Skin stained with 8-oxoguanine Mouse Monoclonal Antibody (CPTC-OGG1-1).
Formalin-fixed, paraffin-embedded human hepatocellular carcinoma stained with TNFAIP3 Mouse Monoclonal Antibody (TNFAIP3/2813).
Antigen retrieval can be achieved using BioCare’s Decloacker, which involves boiling the sections at 95 °C for 45 minutes using Tris-EDTA (10 mM Tris with 1 mM EDTA, pH 9.0) OR citrate buffer (10 mM citrate pH 6.0).
Utilize a hydrophobic marker to establish protective barriers above and below the tissue sections. Exercise caution during this process, as marking too close to the tissue may potentially lead to tissue drying. Therefore, it is advisable to refrain from marking too close to the tissue during this step.
Analyze the stained tissue sections under a microscope and assess the cellular protein localization and expression levels in tissues, which is vital for research and diagnostics.
Formalin-fixed, paraffin-embedded human prostate cancer stained with ABCC4 Mouse Monoclonal Antibody (ABCC4/9179). HIER: Tris/EDTA, pH9.0, 45min. 2°C: HRP-polymer, 30min. DAB, 5min.
Formalin-fixed, paraffin-embedded human prostate cancer stained with ABCC4 Mouse Monoclonal Antibody (ABCC4/9019). Inset: PBS instead of primary antibody; secondary only negative control.
IHC analysis of formalin-fixed, paraffin-embedded human kidney. Stained using ACE2/7203 at 2ug/ml in PBS for 30min RT. HIER: Tris/EDTA, pH9.0, 45min. 2°C: HRP-polymer, 30min. DAB, 5min.
Formalin-fixed, paraffin-embedded human bladder stained with Aciculin Mouse Monoclonal Antibody (PGM5/3552) at 2ug/ml. HIER: Tris/EDTA, pH9.0, 45min. 2 °: HRP-polymer, 30min. DAB, 5min.
Information
© 2026 NeoBiotechnologies. All Rights Reserved.
Monday-Friday: 8:00am – 8:00pm Pacific Time